StockData
ADMA Biologics, Inc. logo

ADMA Biologics, Inc. (ADMA) stock

ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3028% below fair value
$13.56−0.07 (-0.51%)

Close on Nov 18, 2026Market cap $3.04BP/E 19.4Yield –

ADMA Biologics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ADMA Biologics's price to book ratio was 7.3× on Nov 11, 2026, against 10.6× a year earlier. Over the last 5 years it ranged from 1.9× to 24.7×, with a median of 6.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.3×−2.8
2025Dec 31, 202510.1×−7.4
2024Dec 31, 202417.5×+10.7
2023Dec 29, 20236.7×−0.9
2022Dec 30, 20227.6×+5.7
2021Dec 31, 20211.9×−0.6
2020Dec 31, 20202.4×−4.1
2019Dec 31, 20196.6×+3.6
2018Dec 31, 20183.0×−1.3
2017Dec 29, 20174.3×−14.1
2016Oct 31, 201618.4×+0.8
2015Dec 31, 201517.6×+6.4
2014Dec 31, 201411.2×−17.0
2013Oct 31, 201328.2×–

More ADMA Biologics figures

See a number that looks wrong?